Coordinated Tumor Suppression by Chromosome 8p
Darjus F Tschaharganeh1, Benedikt Bosbach1, Scott W Lowe2
1Department of Cancer Biology & Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Abstract:
In this issue of Cancer Cell, Cai et al. use genome editing to study 8p deletions in a mammary epithelial cell model and show that 8p loss of heterozygosity (LOH) attenuates the action of several genes that collectively promote cell invasion and enhance cellular sensitivity to autophagy inhibitors.
Insights
Genome editing revealed that 8p deletions in mammary cells reduce gene activity, hindering cell invasion. This loss of heterozygosity (LOH) also increases sensitivity to autophagy inhibitors, offering new therapeutic targets.
Area of Science:
- Genomics
- Cancer Biology
- Cellular Metabolism
Background:
- Chromosomal deletions, specifically on chromosome 8p, are implicated in various cancers.
- Understanding the functional consequences of 8p loss of heterozygosity (LOH) is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of 8p deletions in mammary epithelial cells using genome editing.
- To determine how 8p LOH affects gene function, cell invasion, and response to autophagy inhibition.
Main Methods:
- Utilized genome editing techniques to create a mammary epithelial cell model with 8p deletions.
- Assessed the impact of 8p LOH on gene expression, cell invasion assays, and sensitivity to autophagy inhibitors.
Main Results:
- Demonstrated that 8p LOH attenuates the activity of multiple genes involved in promoting cell invasion.
- Showed that 8p LOH enhances cellular sensitivity to autophagy inhibitors.
Conclusions:
- 8p LOH plays a significant role in modulating mammary cell behavior, including invasion.
- The increased sensitivity to autophagy inhibitors due to 8p LOH presents a potential therapeutic vulnerability in certain breast cancers.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
07:44Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
Published on: February 17, 2023
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Targeted Cancer Therapies
There are several types of targeted therapies against...
